Improving care for patients with Staphylococcus aureus bacteremia through phone consultations

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance adherence to established guidelines for managing Staphylococcus aureus bacteremia (SAB) by implementing a checklist-based telephone consultation system. The approach involves close monitoring and support for patients diagnosed with SAB during their hospital stay. The study will evaluate the impact of these consultations on clinical outcomes and overall patient care. By focusing on quality improvement, the research seeks to establish effective strategies for managing this serious infection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥ 18 years
* Inpatient treatment at the University Medicine Greifswald university hospital
* First diagnosis of SAB in hospital

Exclusion Criteria:

* SAB already known before admission
* Palliative management within 48 hrs after SAB diagnosis
* Death within 48 hrs after SAB diagnosis
* Hospital discharge within 48hrs after SAB diagnosis

Where it's running

• Greifswald University Medicine
  Greifswald, Germany Recruiting

Study contacts

• Study coordinator: Lena Ulm
• Email: lena.ulm@med.uni-greifswald.de
• Phone: 00493834865569

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combination Antibiotics for Staphylococcus aureus Bacteremia in adults

  This study tests whether using two antibiotics together for adults with Staphylococcus aureus in the blood works better than a single antibiotic.

  Recruiting at 13 sites Phase 4 Intermountain Health Care, Inc. · Brighton, Colorado and 12 other locations · NCT07376889

• Switching to dabigatran versus staying on apixaban/edoxaban/rivaroxaban for S. aureus bloodstream infection

  This trial will try whether switching people with S. aureus bloodstream infection who are already taking apixaban, edoxaban, or rivaroxaban to dabigatran leads to better outcomes.

  Recruiting at 3 sites Phase 4 McGill University Health Centre/Research Institute of the McGill University Health Centre · St. John's, Newfoundland and Labrador and 2 other locations · NCT06650501

• Comparing Daptomycin and Vancomycin for MRSA Bloodstream Infections

  This study is testing whether daptomycin or vancomycin works better for treating bloodstream infections caused by MRSA in patients.

  Recruiting at 20 sites Phase 4 McGill University Health Centre/Research Institute of the McGill University Health Centre · Blacktown, New South Wales and 19 other locations · NCT06637332

• Evaluating treatments for Staphylococcus aureus bloodstream infections

  This study is testing different treatments for people with Staphylococcus aureus bloodstream infections to find out which ones work best to help them recover and live longer.

  Recruiting at 126 sites Phase 4 University of Melbourne · Houston, Texas and 160 other locations · NCT05137119

• Combining two antibiotics to treat Staphylococcus aureus bacteremia

  This study is testing if using two antibiotics together can help adults with Staphylococcus aureus bacteremia get better faster than the usual treatment.

  Recruiting at 8 sites Phase 2 McGill University Health Centre/Research Institute of the McGill University Health Centre · Calgary, Alberta and 7 other locations · NCT04886284

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.